What is the recommended dose of Tessalon (benzonatate) perles for adults and children aged 5 years and older?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Tessalon Perles Dosing

For adults and children over 10 years of age, the recommended dose of Tessalon (benzonatate) is 100-200 mg three times daily as needed for cough, with a maximum daily dose of 600 mg in three divided doses 1.

Standard Dosing Regimen

  • Usual dose: One 100 mg or 200 mg capsule three times daily as needed
  • Maximum daily dose: 600 mg (divided into three doses)
  • Age restriction: Only approved for children 10 years and older 1

Critical Safety Considerations

The capsules must be swallowed whole and never broken, chewed, dissolved, cut, or crushed 1. Release of benzonatate in the mouth produces temporary local anesthesia of oral mucosa and can cause choking. If numbness or tingling of the tongue, mouth, throat, or face occurs, patients should refrain from eating or drinking until numbness resolves 1.

Pediatric Safety Alert

Benzonatate is contraindicated in children under 10 years of age 1. Accidental ingestion has resulted in death in children, with signs of overdose (restlessness, tremors, convulsions, coma, cardiac arrest) occurring within 15-20 minutes and death reported within one hour of ingestion 1. The medication must be kept out of reach of children at all times.

Dosing Context from Clinical Guidelines

In the lung cancer cough management guideline, benzonatate is listed at 100-200 mg four times daily (qid) as a local anesthetic option for opioid-resistant cough that has not responded to other approaches 2. However, the FDA-approved dosing remains three times daily 1, and the guideline context is specifically for palliative care in lung cancer patients, not general cough suppression.

Clinical Efficacy Considerations

Research suggests benzonatate at 200 mg doses did not significantly inhibit cough-reflex sensitivity when used alone in acute viral cough, though combination with guaifenesin showed enhanced effect 3. A 2023 systematic review raised concerns about limited evidence for benzonatate's effectiveness, noting that existing studies have small sample sizes and significant biases 4.

Overdose Risk

Adults can experience fatal overdoses with benzonatate 1. Patients should never exceed a single dose of 200 mg or total daily dose of 600 mg. If a dose is missed, skip it and take the next scheduled dose—never double up 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.